| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |